(Q33338413)

English

Anti-GPIIb/IIIa drugs: current strategies and future directions

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

title

Anti-GPIIb/IIIa drugs: current strategies and future directions (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25 July 2017

Coller BS

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11487034

retrieved

25 July 2017

publication date

1 July 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11487034

retrieved

25 July 2017

published in

Thrombosis and Haemostasis

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11487034

retrieved

25 July 2017

volume

86

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11487034

retrieved

25 July 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11487034

retrieved

25 July 2017

page(s)

427-443

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11487034

retrieved

25 July 2017

Identifiers

PubMed publication ID

11487034

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11487034

retrieved

25 July 2017

(Q33338413)

Anti-GPIIb/IIIa drugs: current strategies and future directions

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)